维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Fiskus W"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Heat shock protein 90 inhibition depletes TrkA levels and signaling in human a- cute leukemia cells 显示文摘	Rao R Nalluri S Fiskus W	2010	Mol Cancer Ther2010，9，：	1
2	Cotreat ment with panobinostatand JAK2 inhibitor TGI01209 attenuates JAK2V617F levels andsignaling and exerts synergistic cytotoxic effects against human my-eloproliferative neoplastic cells 显示文摘	Wang Y Fiskus W Chong DG	2009	Blood2009，114，24：	1
3	Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells显示文摘	Fiskus W Pranpat M Balasis M	2006	Mol Cancer Ther2006，5，12：	1
4	Pan histone deacety- lase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists 显示文摘	Mandawat A Fiskus W Buckley K M	2010	Blood2010，116，24：	1
5	Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells 显示文摘	FISKUS W PRANPAT M BALASIS M	2006	Cancer Res2006，12，19：	1
6	HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells 显示文摘	Rao R Fiskus W Yang Y	2008	Blood2008，112，5：	1
7	Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas显示文摘	Zhang X Zhao X Fiskus W	2012	Cancer Cell2012，22，4：	1
8	HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells显示文摘	Rao R Fiskus W Yang Y	2008	Blood2008，112，5：	1
9	Combination of the histone deacetylase inhibitor LBH589 and the HSP90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3显示文摘	George P Bali P Annavarapu S Scuto A Fiskus W Guo F	2005	Blood2005，105，4：	1
10	Phase I - II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat- induced tubulin acety- lation and Hsp90 inhibition in vivo显示文摘	RAMASWAMY B FISKUS W COHEN B	2012	Breast Cancer Res Treat2012，132，3：	1
11	Preclinical and phase i results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia显示文摘	Williams CB Kambharnpati S Fiskus W	2013	Pharmacothera- py2013，33，12：	1
12	Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the historic deacetylase inhibitor panobinostat against human AML cells显示文摘	Fiskus W Wang Y Sreekumar A	2009	Blood2009，114，：	1
13	Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances deeitabine mediated de- repression of Jun B and loss of survival of human acute leukemia cells 显示文摘	Fiskus W Buckley K Rao R	2009	Cancer Biol Ther2009，8，：	1
14	Phase Ⅰ-Ⅱ study of vorinostat plus paclitaxel and bevacizumab in metastasis breast cancer:evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo显示文摘	Ramaswamy B Fiskus W Cohen B	2012	Breast Cancer Res Treat2012，132，3：	1
15	Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas 显示文摘	Zhang X Zhao X Fiskus W	2012	Cancer Cell2012，22，4：	1
16	Hsp90 inhibitor-me- diated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage显示文摘	Ha K Fiskus W Rao R	2011	Mol Cancer Ther2011，10，7：	1
17	Co treatment with panobinostat and JAK2 inhibitor TG101209 atterative neoplastic cells 显示文摘	Wang Y Fiskus W Chang D G	2009	Blood2009，114，：	1
18	Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute mydoid leukemia cells 显示文摘	Fiskus W Sharma S Qi J	2014	Mol Cancer Ther2014，13，5：	1
19	Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells显示文摘	Rao R Nalluri S Fiskus W	2010	Clin Cancer Res2010，16，：	1
20	Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polyeythaemia vera myelofi- brosis 显示文摘	DeAngelo DJ Mesa RA Fiskus W	2013	Br J Haemato12013，162，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示